Drug intelligence / Profile preview

compound amino acid injection (18AA-VII)

Development stage
Unknown
Lead developer
Jinling Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

18AA-VII is a standardized intravenous compound amino acid solution containing 18 essential and non-essential amino acids. It is primarily utilized in parenteral nutrition to provide a balanced nitrogen source for patients with impaired gastrointestinal function or those in hypermetabolic states, such as critical illness. The formulation is designed to maintain nitrogen balance, promote protein synthesis, and prevent the breakdown of endogenous proteins. In clinical practice, particularly in China where the 18AA-VII nomenclature is standard, it is used to support recovery in surgical patients and those in intensive care units (ICU) by meeting increased metabolic demands. The specific VII designation refers to a formulation ratio optimized for general nutritional support in patients with normal organ function.

Brand names
绿支安Lǜ Zhī Ān
Other names
18 amino acids injection (VII)Compound Amino Acid Injection (18AA-VII)
02

Targets

SERPINA1 (Alpha-1-antitrypsin)

Beyond the preview

Go deeper on compound amino acid injection (18AA-VII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound amino acid injection (18AA-VII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call